Multiple Severe Toxicities of L-Asparaginase and Their Innovative Management during Induction Therapy of Acute Lymphoblastic Leukemia in an Adult Patient
L-asparaginase is a key chemotherapeutic agent in acute lymphoblastic leukemia (ALL). It is also known for multiple and severe specific toxicities, without consensual management. We report the case of a 51-year-old man treated with L-asparaginase for recently diagnosed T-cell ALL. During the treatme...
Saved in:
| Main Authors: | Guillaume Beziat, Suzanne Tavitian, Muriel Picard, Stanislas Faguer, Christian Recher, Françoise Huguet |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-01-01
|
| Series: | Case Reports in Hematology |
| Online Access: | http://dx.doi.org/10.1155/2019/9086570 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Toxicity of L-asparaginase drugs in acute lymphoblastic leukemia treatment
by: T. T. Valiev
Published: (2023-09-01) -
Changes in asparaginase exposure and toxicity profiles in obese pediatric acute lymphoblastic leukemia patients
by: John C. Panetta, et al.
Published: (2025-02-01) -
Asparaginase-associated pancreatitis during therapy for pediatric acute lymphoblastic leukemia
by: M. Beth McCarville, et al.
Published: (2025-08-01) -
Asparaginase dosing for acute lymphoblastic leukemia: more questions than answers
by: Etan Orgel
Published: (2025-04-01) -
Thrombotic and Hemorrhagic Complications in the Treatment of Acute Lymphoblastic Leukemia with L-Asparaginase
by: GM Galstyan, et al.
Published: (2018-01-01)